A 52-year-old man with a positive PPD

JAMA

Volumn 286, Issue 16, 2001, Pages 2015-2022

  Iseman, M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIPIZIDE; ISONIAZID; LISINOPRIL; METFORMIN; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; BANGLADESH; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; HUMAN; INFECTION RISK; MALE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0035944537     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.16.2015     Document Type: Article

References (57)

1. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics
2. The risk of tuberculosis in different groups of the general population
3. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination
4. Global tuberculosis incidence and mortality during 1990-2000
5. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country
6. Groups at risk
7. Global trends in resistance to antituberculosis drugs
8. Efficacy of BCG vaccine in the prevention of tuberculosis: Meta-analysis of the published literature
9. Variation in protection by BCG: Implications of and for heterologous immunity
10. Screening for tuberculosis and tuberculosis infection in high-risk populations, and the use of preventive therapy infection in the United States
11. An epidemiological model of tuberculosis in the United States: TB control: With present methods? with BCG vaccination? or with isoniazid prophylaxis?
12. Controlled chemoprophylaxis trials in tuberculosis: A general review
13. Isoniazid prophylaxis among Alaskan Eskimos: A progress report
14. Five years of follow-up of the IUAT trial of isoniazid prophylaxis in fibrotic lesions
15. The foe of tuberculosis
16. The use and the value of tuberculin in the diagnosis of pulmonary tuberculosis
17. Tuberculin
18. The tuberculin skin test
19. Discrepancies in tuberculin skin test results with two commercial products in a population of intravenous drug users
20. False-positive tuberculin skin test reactions and product viability
21. False positive Aplisol PPD reactions
22. Tuberculin test: Variability with the Mantoux procedure
23. Anergy in active pulmonary tuberculosis
24. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection
25. The tuberculin skin test
26. Factors associated with tuberculin reactivity among the foreign-born in Montreal
27. Targeted tuberculin testing and treatment of latent tuberculosis infection
28. Interpretation of repeated tuberculin tests: Boosting, conversion, and reversion
29. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative: An open study of patients with M. avium complex infection or tuberculosis
30. Pulmonary tuberculosis in patients treated with inhaled beclomethasone
31. Extrapulmonary tuberculosis in the United States
32. Isoniazid associated hepatitis: Report of an outbreak
33. Isoniazid-associated hepatitis in 114 patients
34. The competing risks of tuberculosis and hepatitis for adult tuberculin reactors
35. Isoniazid-related hepatitis: A U.S. Public Health Service Cooperative Surveillance Study
36. Antituberculosis drug-induced hepatotoxicity: The role of hepatitis C virus and the human immunodeficiency virus
37. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: A risk-benefit and cost-effectiveness analysis
38. Should young adults with a positive tuberculin test take isoniazid?
39. Isoniazid preventive therapy: Retrospect and prospect
40. Hepatitis cases in isoniazid treated groups and in a control group
41. Hepatotoxicity associated with isoniazid preventive therapy: A 7-year survey from a public health tuberculosis clinic
42. Twenty isoniazid-associated deaths in one state
43. Severe isoniazid-associated hepatitis - New York, 1991-1993
44. Treatment of tuberculosis and tuberculosis infection in adults and children
45. Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations - United States, 2001
46. Long-term risk of tuberculosis among foreign-born persons in the United States
47. Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide
48. Toxic hepatitis with isoniazid and rifampin: A meta-analysis
49. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection - New York and Georgia, 2000
50. Outcomes of contact investigations of infectious tuberculosis patients
51. Eleven years of community-based directly observed therapy for tuberculosis
52. Short-course chemoprophylaxis for tuberculosis
53. Comparison of sensitivities of two commercially available tuberculin skin test reagents in persons with recent tuberculosis
54. The relative efficacy of respirators and room ventilation in preventing occupational tuberculosis
55. Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992-1995